276 related articles for article (PubMed ID: 10368301)
1. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis.
McTigue MA; Wickersham JA; Pinko C; Showalter RE; Parast CV; Tempczyk-Russell A; Gehring MR; Mroczkowski B; Kan CC; Villafranca JE; Appelt K
Structure; 1999 Mar; 7(3):319-30. PubMed ID: 10368301
[TBL] [Abstract][Full Text] [Related]
2. Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis.
Parast CV; Mroczkowski B; Pinko C; Misialek S; Khambatta G; Appelt K
Biochemistry; 1998 Nov; 37(47):16788-801. PubMed ID: 9843450
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
4. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail.
Shewchuk LM; Hassell AM; Ellis B; Holmes WD; Davis R; Horne EL; Kadwell SH; McKee DD; Moore JT
Structure; 2000 Nov; 8(11):1105-13. PubMed ID: 11080633
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
6. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.
Muller YA; Christinger HW; Keyt BA; de Vos AM
Structure; 1997 Oct; 5(10):1325-38. PubMed ID: 9351807
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
8. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.
Dougher M; Terman BI
Oncogene; 1999 Feb; 18(8):1619-27. PubMed ID: 10102632
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the VEGF binding site on the Flt-1 receptor.
Herley MT; Yu Y; Whitney RG; Sato JD
Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394
[TBL] [Abstract][Full Text] [Related]
10. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
Takahashi T; Yamaguchi S; Chida K; Shibuya M
EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the complex between VEGF and a receptor-blocking peptide.
Wiesmann C; Christinger HW; Cochran AG; Cunningham BC; Fairbrother WJ; Keenan CJ; Meng G; de Vos AM
Biochemistry; 1998 Dec; 37(51):17765-72. PubMed ID: 9922142
[TBL] [Abstract][Full Text] [Related]
12. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.
Mohammadi M; Schlessinger J; Hubbard SR
Cell; 1996 Aug; 86(4):577-87. PubMed ID: 8752212
[TBL] [Abstract][Full Text] [Related]
13. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.
Warner AJ; Lopez-Dee J; Knight EL; Feramisco JR; Prigent SA
Biochem J; 2000 Apr; 347(Pt 2):501-9. PubMed ID: 10749680
[TBL] [Abstract][Full Text] [Related]
14. Crystallization of the receptor binding domain of vascular endothelial growth factor.
Christinger HW; Muller YA; Berleau LT; Keyt BA; Cunningham BC; Ferrara N; de Vos AM
Proteins; 1996 Nov; 26(3):353-7. PubMed ID: 8953654
[TBL] [Abstract][Full Text] [Related]
15. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
16. Folding and Intrinsic Disorder of the Receptor Tyrosine Kinase KIT Insert Domain Seen by Conventional Molecular Dynamics Simulations.
Ledoux J; Trouvé A; Tchertanov L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298994
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.
Mohammadi M; Froum S; Hamby JM; Schroeder MC; Panek RL; Lu GH; Eliseenkova AV; Green D; Schlessinger J; Hubbard SR
EMBO J; 1998 Oct; 17(20):5896-904. PubMed ID: 9774334
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.
Zhu Z; Lu D; Kotanides H; Santiago A; Jimenez X; Simcox T; Hicklin DJ; Bohlen P; Witte L
Cancer Lett; 1999 Mar; 136(2):203-13. PubMed ID: 10355750
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
20. The three-dimensional structure of the ZAP-70 kinase domain in complex with staurosporine: implications for the design of selective inhibitors.
Jin L; Pluskey S; Petrella EC; Cantin SM; Gorga JC; Rynkiewicz MJ; Pandey P; Strickler JE; Babine RE; Weaver DT; Seidl KJ
J Biol Chem; 2004 Oct; 279(41):42818-25. PubMed ID: 15292186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
